Clinical Trial Update: Leptin to Treat Lipodystrophy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating leptin as a treatment for lipodystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipodystrophy

Drugs mentioned

• Leptin (leptin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Lipodystrophy | Phase 2 | Status: COMPLETED